|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0087111,
umls-concept:C0205179,
umls-concept:C0205420,
umls-concept:C0282460,
umls-concept:C0332283,
umls-concept:C0443196,
umls-concept:C0543467,
umls-concept:C0684249,
umls-concept:C1274040,
umls-concept:C1517927,
umls-concept:C1522449,
umls-concept:C1527178,
umls-concept:C1559154,
umls-concept:C1705938,
umls-concept:C2347669
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1998-3-2
|
|
pubmed:abstractText |
To evaluate the feasibility and efficacy of an intensive multimodality approach with combination chemotherapy, hyperfractionated accelerated chemoradiotherapy, and definitive surgery in prognostically unfavorable subgroups of locally advanced non-small-cell lung cancer stages IIIA and IIIB (LAD-NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BudachVV,
pubmed-author:EberhardtWW,
pubmed-author:FlasshoveMM,
pubmed-author:GreschuchnaDD,
pubmed-author:HarstrickAA,
pubmed-author:KonietzkoNN,
pubmed-author:KrauseBB,
pubmed-author:MüellerM RMR,
pubmed-author:MenkerHH,
pubmed-author:SackHH,
pubmed-author:SeeberSS,
pubmed-author:StahlMM,
pubmed-author:StamatisGG,
pubmed-author:StuschkeMM,
pubmed-author:WilkeHH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
622-34
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:9469351-Adult,
pubmed-meshheading:9469351-Aged,
pubmed-meshheading:9469351-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9469351-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:9469351-Cisplatin,
pubmed-meshheading:9469351-Combined Modality Therapy,
pubmed-meshheading:9469351-Dose Fractionation,
pubmed-meshheading:9469351-Etoposide,
pubmed-meshheading:9469351-Female,
pubmed-meshheading:9469351-Humans,
pubmed-meshheading:9469351-Lung Neoplasms,
pubmed-meshheading:9469351-Male,
pubmed-meshheading:9469351-Middle Aged,
pubmed-meshheading:9469351-Postoperative Complications,
pubmed-meshheading:9469351-Radiotherapy Dosage,
pubmed-meshheading:9469351-Survival Rate
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.
|
|
pubmed:affiliation |
Department of Internal Medicine (Cancer Research), West German Cancer Center, University of Essen Medical School, Essen-Heidhausen, Germany. wilfried.eberhardt@uni-essen.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
